[FATE] QoQ Quarter Result on 30-Jun-2020 [#Q2]

Stock
[FATE] Fate Therapeutics, Inc.
Announcement Date
05-Aug-2020
Financial Year
2020
Quarter
30-Jun-2020 [#Q2]
Profit Trend
QoQ- 16.25%
YoY- -19.57%
Quarter Report
FATE's Result
FATE's Financial Summary
View:
Show?
Quarter Result
31/03/21 31/12/20 30/09/20 30/06/20 31/03/20 31/12/19 30/09/19 CAGR
Revenue 11,142 15,896 7,558 5,465 2,515 2,802 2,429 175.81%
PBT -45,089 -53,112 -58,684 -28,072 -33,520 -28,302 -26,609 42.08%
Tax -1,121 -861 0 635 0 691 910 -
NP -45,089 -53,112 -58,684 -28,072 -33,520 -28,302 -26,609 42.08%
Tax Rate - - - - - - - -
Total Cost 56,231 69,008 66,242 33,537 36,035 31,104 29,038 55.29%
Ratio Analysis
31/03/21 31/12/20 30/09/20 30/06/20 31/03/20 31/12/19 30/09/19 CAGR
NP Margin -404.68 -334.12 -776.45 -513.67 -1,332.80 -1,010.06 -1,095.47 -48.48%
Per Share
31/03/21 31/12/20 30/09/20 30/06/20 31/03/20 31/12/19 30/09/19 CAGR
EPS -0.48 -0.61 -0.68 -0.35 -0.44 -0.37 -0.40 12.91%
EPS Diluted -0.48 -0.61 -0.68 -0.35 -0.44 -0.37 -0.40 12.91%

PBT = Profit before Tax, NP = Net Profit, NP Margin = Net Profit Margin, EPS = Earning Per Share, EPS Diluted = Earning Per Share Diluted.

NP Margin, QoQ ⃤ & YoY ⃤ figures in Percentage; EPS & EPS Diluted figures in Cent.

All figures in '000 unless specified.